The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)

NCT ID: NCT04197453

Last Updated: 2021-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

752 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-06

Study Completion Date

2020-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

cvMOBIUS is a North American registry of patients with ASCVD aimed at understanding patterns of care in ASCVD while evaluating the real world effectiveness of PCSK9 inhibitors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this registry is to evaluate the effectiveness of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9i) to reduce cardiovascular events among subjects presenting with a recent atherosclerotic cardiovascular disease (ASCVD) event in real-world practice. A total of 8500 patients with a recent cardiovascular event who are likely to be eligible for non-statin lipid lowering therapy will be enrolled and followed prospectively for five years. In addition, the study will assess longitudinal patterns of lipid control, clinical outcomes, and LLT including statins, ezetimibe, and PCSK9 inhibitors in adults with an ASCVD event and/or revascularization. This study will also compare the clinical characteristics and outcomes of subjects enrolled in both arms of the registry to understand the strengths and limitations of data harvested directly from electronic health record (EHR) systems as compared with prospectively collected information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ASCVD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Consented Arm

Subjects with a recent (within 18 months) hospitalization for myocardial infarction, unstable angina, ischemic stroke, or critical limb ischemia, and subjects undergoing coronary, peripheral, or carotid revascularization, including surgical and percutaneous revascularization, with an LDL-C greater than or equal to 70 mg/dL who may be eligible for PCSK9 inhibitor therapy.

No interventions assigned to this group

Electronic Health Record (EHR) arm

Subjects with an inpatient or outpatient diagnosis of clinical ASCVD within the prior 12 months including coronary heart disease, ischemic cerebrovascular disease, atherosclerotic peripheral arterial disease, or prior coronary or peripheral or carotid revascularization.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age ≥ 40 years
* One or both of the following:

* Hospitalization for a clinical ASCVD event: acute (MI), UA, IS, or critical limb ischemia (CLI) within 18 months of enrollment NOTE: subjects must have been admitted to the hospital. Those who are admitted and discharged in less than 24 hours are eligible for the study. Subjects who have been admitted to the ER for a clinical ASCVD event and not admitted to the hospital are not eligible for enrollment.
* Coronary, peripheral, or carotid revascularization including percutaneous or surgical revascularization in the past 18 months Note: Revascularization procedures can occur in the inpatient or outpatient setting.
* One of the following:

* Low-density lipoprotein (LDL) ≥ 70 mg/dL (1.81 mmol/L) with no plans for immediate initiation or titration of statin therapy (Note: Subjects should not be enrolled into study during initiation/titration of statins until they have a stable LDL-C measurement \> 4 weeks after their last statin change and no immediate plans for future titration).
* Newly started on PCSK9i after the index hospitalization/procedure and prior to enrollment (but no more than 6 months prior to enrollment) with pre-PCSK9i treatment LDL-C value available and known background LLT any time prior to PCSK9i initiation.
* Planned follow-up within the health system.

Exclusion Criteria

* Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)
* Lack of phone or email for contact
* Evidence of end stage renal disease (ESRD) or stage 5 chronic kidney disease (CKD)
* Anticipated life expectancy less than 6 months
* On a PCSK9i prior to their qualifying event; Note: Subjects with prior PCSK9i use occurring and ending before the 12-month period prior to enrollment and before the index ASCVD event will be considered for inclusion.

EHR Arm Criteria:

Subjects are eligible to be included in the "EHR arm" of the registry if they are:

* Adults age ≥ 40 years of age
* Have at least 1 inpatient or outpatient diagnosis of clinical ASCVD within 12 months prior to enrollment including CHD, ischemic cerebrovascular disease, atherosclerotic PAD, or prior coronary or peripheral or carotid revascularization.
Minimum Eligible Age

40 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke Clinical Research Institute

OTHER

Sponsor Role collaborator

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Mercy Gilbert Medical Center

Gilbert, Arizona, United States

Site Status

Old Pueblo Cardiology

Tucson, Arizona, United States

Site Status

Cardiovascular Research Foundation of Southern California

Beverly Hills, California, United States

Site Status

Los Alamitos Cardiovascular

Los Alamitos, California, United States

Site Status

Consortium of Attending Physicians for Research Investigations LLC

Los Angeles, California, United States

Site Status

Nanavati Critical Care Cardiology Clinic

National City, California, United States

Site Status

Rancho Cucamonga Clinical Trials

Rancho Cucamonga, California, United States

Site Status

Eisenhower Desert Cardiology Center

Rancho Mirage, California, United States

Site Status

San Diego Cardiac Center

San Diego, California, United States

Site Status

Millennium Clinical Trials

Thousand Oaks, California, United States

Site Status

Central Coast Cardiovascular

Ventura, California, United States

Site Status

University of Colorado Memorial Health System

Colorado Springs, Colorado, United States

Site Status

Hartford Hospital

Hartford, Connecticut, United States

Site Status

Cardiology Associates of Fairfield County, PC

Stamford, Connecticut, United States

Site Status

Bay Area Cardiology

Brandon, Florida, United States

Site Status

Holy Cross Hospital Inc

Fort Lauderdale, Florida, United States

Site Status

The Cardiac and Vascular Institute Research

Gainesville, Florida, United States

Site Status

Baptist Heart Specialists

Jacksonville Beach, Florida, United States

Site Status

Southwest Florida Research LLC

Naples, Florida, United States

Site Status

Ocala Cardiovascular Research

Ocala, Florida, United States

Site Status

Palm Harbor Medical Associates

Palm Harbor, Florida, United States

Site Status

Cardiology Consultants

Pensacola, Florida, United States

Site Status

Genesis Clinical Research Inc

Tampa, Florida, United States

Site Status

Interventional Cardiac Consultants

Trinity, Florida, United States

Site Status

Albany Internal Medicine

Albany, Georgia, United States

Site Status

Piedmont Heart Institute

Atlanta, Georgia, United States

Site Status

Accel Research Sites

Atlanta, Georgia, United States

Site Status

First Georgia Physicians Group

Fayetteville, Georgia, United States

Site Status

Northwest Heart Clinical Research LLC

Arlington Heights, Illinois, United States

Site Status

John H Stroger Jr Hospital of Cook County

Chicago, Illinois, United States

Site Status

Evanston Premier Healthcare Research LLC

Evanston, Illinois, United States

Site Status

Advocate Lutheran General Hospital

Park Ridge, Illinois, United States

Site Status

Prairie Cardiovascular Consultants

Springfield, Illinois, United States

Site Status

Indiana University

Indianapolis, Indiana, United States

Site Status

Saint Vincent Heart Center

Indianapolis, Indiana, United States

Site Status

Reid Physician Associates

Richmond, Indiana, United States

Site Status

Midwest Cardiovascular Research Foundation

Davenport, Iowa, United States

Site Status

MercyOne Iowa Heart Center

West Des Moines, Iowa, United States

Site Status

The University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Midwest Heart and Vascular Specialists

Overland Park, Kansas, United States

Site Status

Premier Medical Group

Owensboro, Kentucky, United States

Site Status

Grace Research LLC

Bossier City, Louisiana, United States

Site Status

Heart Clinic of Hammond

Hammond, Louisiana, United States

Site Status

Clinical Trials of America Inc

Monroe, Louisiana, United States

Site Status

University Medical Center-New Orleans

New Orleans, Louisiana, United States

Site Status

Ochsner Health Systems

New Orleans, Louisiana, United States

Site Status

Willis Knighton Cardiology

Shreveport, Louisiana, United States

Site Status

Grace Research LLC

Shreveport, Louisiana, United States

Site Status

Louisiana Heart Center

Slidell, Louisiana, United States

Site Status

MedStar Health Research Institute Chesapeake Cardiovascular Associates

Hyattsville, Maryland, United States

Site Status

TidalHealth Peninsula Regional, Inc

Salisbury, Maryland, United States

Site Status

McLaren Health

Bay City, Michigan, United States

Site Status

Henry Ford Hospital

Detroit, Michigan, United States

Site Status

Genesys Regional Medical Center

Grand Blanc, Michigan, United States

Site Status

Michigan Heart

Ypsilanti, Michigan, United States

Site Status

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, United States

Site Status

Jackson Heart

Jackson, Mississippi, United States

Site Status

Missouri Cardiovascular Specialists

Columbia, Missouri, United States

Site Status

University of Missouri Health Care

Columbia, Missouri, United States

Site Status

Cox Medical Centers

Springfield, Missouri, United States

Site Status

Washington University

St Louis, Missouri, United States

Site Status

Saint Louis Heart and Vascular PC

St Louis, Missouri, United States

Site Status

Methodist Physicians Clinic Heart Consultants

Omaha, Nebraska, United States

Site Status

Palm Research Center Inc

Las Vegas, Nevada, United States

Site Status

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

Advanced Heart Care LLC

Bridgewater, New Jersey, United States

Site Status

Advanced Cardiology LLC

Cedar Knolls, New Jersey, United States

Site Status

Overlook Hospital

Summit, New Jersey, United States

Site Status

Virtua Health, Inc.

Voorhees Township, New Jersey, United States

Site Status

Albany Medical College

Albany, New York, United States

Site Status

Bassett Healthcare

Cooperstown, New York, United States

Site Status

Long Island Cardiovascular Consultants

Lake Success, New York, United States

Site Status

SJH Cardiology Associates

Liverpool, New York, United States

Site Status

Winthrop University Hospital

Mineola, New York, United States

Site Status

Northwell Health

New York, New York, United States

Site Status

DiGiovanna Institute for Medical Education and Research

North Massapequa, New York, United States

Site Status

Circuit Clinic

Orchard Park, New York, United States

Site Status

Saratoga Clinical Research, LLC

Saratoga Springs, New York, United States

Site Status

Stony Brook University Hospital

Stony Brook, New York, United States

Site Status

Montefiore Medical Center - Bronx

The Bronx, New York, United States

Site Status

Duke Heart Center Clinical Research

Durham, North Carolina, United States

Site Status

Cone Health

Greensboro, North Carolina, United States

Site Status

Medication Management, LLC

Greensboro, North Carolina, United States

Site Status

Vidant Cardiology

Greenville, North Carolina, United States

Site Status

Novant Health Heart and Vascular Institute

Monroe, North Carolina, United States

Site Status

Coastal Carolina Health Care PA

New Bern, North Carolina, United States

Site Status

Pinehurst Medical Clinic, Inc

Pinehurst, North Carolina, United States

Site Status

WakeMed

Raleigh, North Carolina, United States

Site Status

Sanford Cardiology

Sanford, North Carolina, United States

Site Status

PMG Research of Piedmont HealthCare

Statesville, North Carolina, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

The Ohio State University, Wexner Medical Center

Columbus, Ohio, United States

Site Status

Premier Cardiovascular

Dayton, Ohio, United States

Site Status

Kettering Medical Center

Kettering, Ohio, United States

Site Status

Heart House Research Foundation

Springfield, Ohio, United States

Site Status

Saint Vincent Medical Center

Toledo, Ohio, United States

Site Status

Central Oklahoma Early Detection Center

Edmond, Oklahoma, United States

Site Status

Ascension St John Clinical Research Institute

Tulsa, Oklahoma, United States

Site Status

Oklahoma State University Health Science Center

Tulsa, Oklahoma, United States

Site Status

Lynn Institute of Tulsa

Tulsa, Oklahoma, United States

Site Status

Central PA Physicians Group

Altoona, Pennsylvania, United States

Site Status

Capital Area Research LLC

Camp Hill, Pennsylvania, United States

Site Status

Chambersburg Hospital

Chambersburg, Pennsylvania, United States

Site Status

Doylestown Health Cardiology

Doylestown, Pennsylvania, United States

Site Status

The Heart Group of Lancaster General Health

Lancaster, Pennsylvania, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Kent Hospital

Warwick, Rhode Island, United States

Site Status

AnMed Health

Anderson, South Carolina, United States

Site Status

PMG Research of Charleston

Charleston, South Carolina, United States

Site Status

Columbia Heart

Columbia, South Carolina, United States

Site Status

Upstate Cardiology

Greenville, South Carolina, United States

Site Status

Monument Health Clinical Research

Rapid City, South Dakota, United States

Site Status

Diagnostic Cardiology Group

Chattanooga, Tennessee, United States

Site Status

Stern Cardiovascular Foundation Inc

Germantown, Tennessee, United States

Site Status

Parkway Cardiology Associates

Oak Ridge, Tennessee, United States

Site Status

Seton Heart Institute

Austin, Texas, United States

Site Status

Thyroid Endocrinology and Diabetes

Dallas, Texas, United States

Site Status

Southwest Family Medicine Associates

Dallas, Texas, United States

Site Status

Baylor College of Medicine

Houston, Texas, United States

Site Status

Northwest Houston Cardiology

Houston, Texas, United States

Site Status

North Dallas Research Associates

McKinney, Texas, United States

Site Status

CardioVoyage

McKinney, Texas, United States

Site Status

Texas Institute of Cardiology

McKinney, Texas, United States

Site Status

Southern Endocrinology Associates PA

Mesquite, Texas, United States

Site Status

Permian Research Foundation

Odessa, Texas, United States

Site Status

Consano Clinical Research

San Antonio, Texas, United States

Site Status

San Antonio Endovascular and Heart Institute

San Antonio, Texas, United States

Site Status

Village Medical Centers

The Woodlands, Texas, United States

Site Status

Northwest Houston Heart Center

Tomball, Texas, United States

Site Status

Tyler Cardiovascular Consultants

Tyler, Texas, United States

Site Status

Cardiology Consultants of Danville, Inc

Danville, Virginia, United States

Site Status

Virginia Heart

Falls Church, Virginia, United States

Site Status

Stroobants Cardiovascular Center

Lynchburg, Virginia, United States

Site Status

Carient Heart and Vascular

Manassas, Virginia, United States

Site Status

Cardiovascular Associates of Virginia

Midlothian, Virginia, United States

Site Status

Tidewater Physicians Multispecialty Group Clinical Research

Newport News, Virginia, United States

Site Status

York Clinical Research LLC

Norfolk, Virginia, United States

Site Status

Multicare Institute for Research and Innovation

Puyallup, Washington, United States

Site Status

Washington University

Seattle, Washington, United States

Site Status

Marshall Cardiology

Huntington, West Virginia, United States

Site Status

West Virginia University

Morgantown, West Virginia, United States

Site Status

Fraser River Endocrinology

Surrey, British Columbia, Canada

Site Status

Cardio Metabolic Collaborative Clinic

Victoria, British Columbia, Canada

Site Status

Discovery Clinical Services Ltd

Victoria, British Columbia, Canada

Site Status

Winnipeg Clinic

Winnipeg, Manitoba, Canada

Site Status

South Sherbrook Health Centre and Pharmacy

Winnipeg, Manitoba, Canada

Site Status

Cardio 1

Winnipeg, Manitoba, Canada

Site Status

Brampton Clinical Trials

Brampton, Ontario, Canada

Site Status

Cambridge Cardiac Care Centre

Cambridge, Ontario, Canada

Site Status

Saul Vizel Professional Medicine Corporation â€" Vizel Cardiac Research

Cambridge, Ontario, Canada

Site Status

Cardiovasular Clinical Research Organization Limited

Greater Sudbury, Ontario, Canada

Site Status

Curnew Medicine Professional Corporation

Hamilton, Ontario, Canada

Site Status

Partners in Advanced Cardiac Evaluation

Newmarket, Ontario, Canada

Site Status

Oakville Cardiovascular Research Limited Partnership

Oakville, Ontario, Canada

Site Status

Rhema Research Institute

Owen Sound, Ontario, Canada

Site Status

Heart Health Institute Research Incorporated

Scarborough Village, Ontario, Canada

Site Status

Sewa Ram Singal Medicine Professional Corporation

Toronto, Ontario, Canada

Site Status

Mohan Babapulle Medicine Professional Corporation

Waterloo, Ontario, Canada

Site Status

Ecogene-21

Chicoutimi, Quebec, Canada

Site Status

McGill University Health Centre - Montreal General Hospital

Montreal, Quebec, Canada

Site Status

Applied Medical Informatics Research Incorporated

Montreal, Quebec, Canada

Site Status

CardioVasc HR Incorporated

Saint-Jean-sur-Richelieu, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20180059

Identifier Type: -

Identifier Source: org_study_id